Two regions of homozygosity on chromosome 3p in squamous cell carcinoma of the head and neck: comparison with cytogenetic analysis
- PMID: 8902566
- DOI: 10.1002/(SICI)1097-0347(199611/12)18:6<529::AID-HED7>3.0.CO;2-4
Two regions of homozygosity on chromosome 3p in squamous cell carcinoma of the head and neck: comparison with cytogenetic analysis
Abstract
Background: Loss effecting the short arm of chromosome 3 occurs in nearly 60% of squamous cell carcinomas of the head and neck (SCCHN). Karyotype analysis indicated that these losses occur in two regions, 3p13-p14 and 3p21-p24. To test these findings, we examined tumor DNA from 38 SCCHN cell lines for heterozygosity and homozygosity at 6 polymorphic loci spanning this region.
Methods: The polymerase chain reaction (PCR) was used to amplify polymorphic restriction sites on 3p, the amplified products were digested with the appropriate restriction enzyme, electrophoresed on agarose gels, and assessed for the presence of one or both alleles. The 38 SCCHN cell lines were established from 31 patients and included 16 that had been karyotyped. In 6 cases two or three tumor cell lines established from separate tumors in the same patients were studied.
Results: The cell lines exhibited a very low frequency of heterozygosity for the regions 3p12-3p21 (D3S3, D3S30 and D3S2) and distal 3p21-3p24 (D3F15S2 and THRB), when compared with that observed in the normal population. In contrast, D3S32, located within 3p21, was heterozygous in 38% of the tumors which is close to the frequency seen in the normal population (50%). In most cases the PCR results were consistent with the cytogenetic predictions. However, in 4 cell lines 3p loss was predicted from the karyotype, but heterozygosity for D3S32 was present.
Conclusions: These experiments support cytogenetic data that indicate two regions of 3p loss in SCCHN tumors. The 3p regions that show a high frequency of homozygosity may contain tumor suppressor genes involved in the development and/or progression of squamous cancer. The region surrounding D3S32 may contain an essential gene that is conserved in two copies even when much of 3p is lost.
Similar articles
-
Chromosome 3p deletions in head and neck carcinomas: statistical ascertainment of allelic loss.Cancer Res. 1992 Mar 15;52(6):1451-6. Cancer Res. 1992. PMID: 1540952
-
Three discrete regions of deletion at 3p in head and neck cancers.Cancer Res. 1993 Dec 1;53(23):5775-9. Cancer Res. 1993. PMID: 8242635
-
Polymerase chain reaction-based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma.Cancer. 1993 Aug 1;72(3):881-6. doi: 10.1002/1097-0142(19930801)72:3<881::aid-cncr2820720337>3.0.co;2-q. Cancer. 1993. PMID: 8101470
-
Genomic instability in squamous cell carcinoma of the head and neck.Anticancer Res. 1996 Jul-Aug;16(4C):2421-31. Anticancer Res. 1996. PMID: 8816845 Review.
-
Cytogenetics in head and neck cancer.Otolaryngol Clin North Am. 1992 Oct;25(5):1073-87. Otolaryngol Clin North Am. 1992. PMID: 1408192 Review.
Cited by
-
Computational Models Accurately Predict Multi-Cell Biomarker Profiles in Inflammation and Cancer.Sci Rep. 2019 Jul 26;9(1):10877. doi: 10.1038/s41598-019-47381-4. Sci Rep. 2019. PMID: 31350446 Free PMC article.
-
Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation models.Cancer Immunol Immunother. 2016 Dec;65(12):1511-1522. doi: 10.1007/s00262-016-1907-5. Epub 2016 Sep 29. Cancer Immunol Immunother. 2016. PMID: 27688163 Free PMC article.
-
Malignant and nonmalignant gene signatures in squamous head and neck cancer.J Oncol. 2012;2012:752860. doi: 10.1155/2012/752860. Epub 2012 Apr 12. J Oncol. 2012. PMID: 22570652 Free PMC article.
-
The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.Oral Oncol. 2007 Aug;43(7):701-12. doi: 10.1016/j.oraloncology.2006.09.001. Epub 2006 Nov 16. Oral Oncol. 2007. PMID: 17112776 Free PMC article.
-
Molecular characterization of head and neck cancer: how close to personalized targeted therapy?Mol Diagn Ther. 2012 Aug 1;16(4):209-22. doi: 10.2165/11635330-000000000-00000. Mol Diagn Ther. 2012. PMID: 22873739 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous